相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
N. Yang et al.
ONCOGENE (2017)
CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Y. Zhao et al.
ONCOGENE (2016)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N. Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
Valery Adorno-Cruz et al.
CANCER RESEARCH (2015)
Targeting transcription is no longer a quixotic quest
Anna K. Mapp et al.
NATURE CHEMICAL BIOLOGY (2015)
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C. U. Cheang et al.
ONCOLOGIST (2015)
The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA
Ming Wang et al.
Oncotarget (2015)
Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin
King Chi Chan et al.
SCIENTIFIC REPORTS (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Heinz-Josef Lenz et al.
CANCER SCIENCE (2014)
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
E. J. Gang et al.
ONCOGENE (2014)
Targeting FOXM1 in cancer
Marianna Halasi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Estimation of rat mammary tumor volume using caliper and ultrasonography measurements
Ana Faustino-Rocha et al.
LAB ANIMAL (2013)
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
Aleix Prat et al.
ONCOLOGIST (2013)
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Novel functions of FoxM1: from molecular mechanisms to cancer therapy
Monica Alvarez-Fernandez et al.
FRONTIERS IN ONCOLOGY (2013)
The wnt/beta-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
Taj D. King et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma
Hui Chen et al.
JOURNAL OF GENE MEDICINE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
Robin M. Hallett et al.
PLOS ONE (2012)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs
Mario Cioce et al.
CELL CYCLE (2010)
A complex task? Direct modulation of transcription factors with small molecules
Angela N. Koehler
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
J. Millour et al.
ONCOGENE (2010)
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Yingzi Wang et al.
SCIENCE (2010)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
Theresa A. DiMeo et al.
CANCER RESEARCH (2009)
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Jimmy M-M. Kwok et al.
MOLECULAR CANCER THERAPEUTICS (2008)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Wnt/β-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency
Tomoyuki Miyabayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Antibiotic susceptibility of mammalian mitochondrial translation
L Zhang et al.
FEBS LETTERS (2005)
Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression
H Ma et al.
ONCOGENE (2005)
Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators
ML Major et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
KH Emami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates
A Hecht et al.
EMBO JOURNAL (2000)
分享论文
